Cargando…
A Novel Galantamine-Curcumin Hybrid as a Potential Multi-Target Agent against Neurodegenerative Disorders
The acetylcholinesterase (AChE) inhibitors are the main drugs for symptomatic treatment of neurodegenerative disorders like Alzheimer’s disease. A recently designed, synthesized and tested hybrid compound between the AChE inhibitor galantamine (GAL) and the antioxidant polyphenol curcumin (CU) showe...
Autores principales: | Simeonova, Rumyana, Zheleva, Dimitrina, Valkova, Iva, Stavrakov, Georgi, Philipova, Irena, Atanasova, Mariyana, Doytchinova, Irini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037483/ https://www.ncbi.nlm.nih.gov/pubmed/33806197 http://dx.doi.org/10.3390/molecules26071865 |
Ejemplares similares
-
Ex Vivo Antioxidant and Cholinesterase Inhibiting Effects of a Novel Galantamine–Curcumin Hybrid on Scopolamine-Induced Neurotoxicity in Mice
por: Simeonova, Rumyana, et al.
Publicado: (2022) -
Galantamine-Curcumin Hybrids as Dual-Site Binding Acetylcholinesterase Inhibitors
por: Stavrakov, Georgi, et al.
Publicado: (2020) -
A Galantamine–Curcumin Hybrid Decreases the Cytotoxicity of Amyloid-Beta Peptide on SH-SY5Y Cells
por: Mladenova, Kirilka, et al.
Publicado: (2021) -
Novel hits for acetylcholinesterase inhibition derived by docking-based screening on ZINC database
por: Doytchinova, Irini, et al.
Publicado: (2018) -
Discovery of a Novel Acetylcholinesterase Inhibitor by Fragment-Based Design and Virtual Screening
por: Stavrakov, Georgi, et al.
Publicado: (2021)